Skip to main content
SpringerLink
Log in

Inositolphosphoglycans are possible mediators of the glucagon-like peptide 1 (7–36)amide action in the liver

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

A potent glycogenic effect for GLP-1 (7–36)amide has been found in rat hepatocytes and skeletal muscle, and the specific receptors detected for GLP-1 (27–36)amide in these tissue membranes do not seem to be associated to adenylate cyclase. On the other hand, inositolphosphoglycan molecules (IPGs) have been implicated as second messengers in the action of insulin. In a human hepatoma cell line (HEP G-2), we have observed the presence of [125I]GLP-1(7–36)amide specific binding, and a stimulatory effect of the peptide upon glycogen synthesis, confirming the findings in isolated rat hepatocytes. Also, GLP-1 (7–36)amide modulates the cell content of radiolabelled glycosylphosphatidylinositols (GPIs), in the same manner as insulin, indicating hydrolysis of GPIs and an immediate and short-lived generation of IPGs. Thus, IPGs could be mediators in the GLP-1 (7–36)amide glycogenic action in the liver.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Valverde I., Morales M., Clemente F., López-Delgado M.I., Delgado E., Perea A., Villanueva-Penacarrillo M.L. Glucagon-like peptide 1: a potent glycogenic hormone. FEBS Lett. 349: 313, 1994.

    Article  PubMed  CAS  Google Scholar 

  2. Villanueva-Penacarrillo M.L., Alcántara A., Clemente F., Delgado E., Valverde I. Potent glycogenic effect of GLP-1(7–36)amide in rat skeletal muscle. Diabetologia 37: 1163, 1994.

    Article  PubMed  CAS  Google Scholar 

  3. Villanueva-Penacarrillo M.L., Delgado E., Trapote MA, Alcántara A., Clemente F., Luque M.A., Perea A., Valverde I. Glucagon-like peptide-1 binding to rat hepatic membranes. J. Endocrinol. 146: 183, 1995.

    Article  PubMed  CAS  Google Scholar 

  4. Delgado E., Luque M.A., Alcántara A., Trapote M.A., Clemente F., Galera C., Valverde I., Villanueva-Peñacarrillo M.L. Glucagon-like peptide-1 binding to rat skeletal muscle. Peptides 16: 225, 1995.

    Article  PubMed  CAS  Google Scholar 

  5. Thorens B. Expression cloning of the pancreatic ß cell receptor for the gluco-incretin hormone glucagon-like peptide 1. Proc. Natl. Acad. Sci. USA 89: 8641, 1992.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  6. Drucker D.J., Philippe J., Mojsov S., Chick W.L., Habener J.F. Glucagon-like peptide I stimulates insulin gene expression and increases cyclic AMP levels in a rat islet cell line. Proc. Natl. Acad. Sci. USA 84: 3434, 1987.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  7. Irvine F., Wallace A.V., Sarawak S.R., Houslay M.D. Extracellular calcium modulates insulin’s action on enzymes controlling cyclic AMP metabolism in intact hepatocytes. Biochem. J. 293: 249, 1993.

    PubMed Central  PubMed  CAS  Google Scholar 

  8. Rosen O.M. After insulin binds. Science 237: 1452, 1987.

    Article  PubMed  CAS  Google Scholar 

  9. Saltiel A.R., Cuatrecasas P. Insulin stimulates the generation from hepatic plasma membranes of modulators derived from an inositol glycolipid. Proc. Natl. Acad. Sci. USA 83: 5793, 1986.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  10. Saltiel A.R., Fox J.A., Sherline P., Cuatrecasas P. Insulin-stimulated hydrolysis of a novel glycolipid generates modulators of cAMP phosphodiesterase. Science 233: 967, 1986.

    Article  PubMed  CAS  Google Scholar 

  11. Lamer J., Galasko G., Cheng K., DePaoli-Roach A.A., Huang L., Daggy P., Kellogg J. Generation by insulin of a chemical mediator that controls protein phosphorylation and dephosphorylation. Science 206: 1408, 1979.

    Article  Google Scholar 

  12. Jarett L., Seals J.R. Pyruvate dehydrogenase activation in adipocyte mitochondria by an insulin-generated mediator from muscle. Science 206: 1407, 1979.

    Article  PubMed  CAS  Google Scholar 

  13. Suzuki S., Toyota T., Suzuki H., Goto Y. A putative second messenger of insulin action regulates hepatic microsomal glucose-6-phosphatase. Biochem. Biophys. Res. Commun. 118: 40, 1984.

    Article  PubMed  CAS  Google Scholar 

  14. Suzuki S., Toyota T., Suzuki H., Goto Y. Partial purification from human mononuclear cells and placental plasma membranes of an insulin mediator which stimulates pyruvate dehydrogenase and suppresses glucose-6-phosphatase. Arch. Biochem. Biophys. 235: 418, 1984.

    Article  PubMed  CAS  Google Scholar 

  15. Larner J. Insulin-signaling mechanisms. Lessons from the old testament of glycogen metabolism and the new testament of molecular biology. Diabetes 37: 262, 1988.

    CAS  Google Scholar 

  16. Mato J.M., Kelly K.L., Abler A., Jarett L. Identification of a novel insulin-sensitive glycophospholipid from H35 hepatoma cells. J. Biol. Chem. 262: 2131, 1987.

    PubMed  CAS  Google Scholar 

  17. Sánchez-Arias J.A., Sánchez-Gutiérrez J.C., Guadaño A., Alvarez J.F., Samper B., Mato J.M., Feliu J.E. Impairment of glycosyl-phosphatidylinositol-dependen insulin signaling system in isolated rat hepatocytes by streptozotocin-induced diabetes. Endocrinology 131: 1727, 1992.

    PubMed  Google Scholar 

  18. Farese R.V., Cooper D.R., Konda T.S., Nair G., Standaert M.L., Pollet R.J. Insulin provokes coordinated increases in the synthesis of phosphatidylinositol, phosphatidylinositol phosphates and the phosphatidylinositolglycan in BC3H-1 myocytes. Biochem. J. 256: 185, 1988.

    PubMed Central  PubMed  CAS  Google Scholar 

  19. Romero G., Luttrell L, Rogol A., Zeller K., Hewlett E., Larner J. Phosphatidylinositol-glycan anchors of membrane proteins: potential precursors of insulin mediators. Science 240: 509, 1988.

    Article  PubMed  CAS  Google Scholar 

  20. Mato J.M., Kelly K.L., Abler A., Jarett L., Corkey B.E., Cashel J.A., Zopf D. Partial structure of an insulin-sensitive glycophospholipid. Biochem. Biophys. Res. Commun. 146: 764, 1987.

    Article  PubMed  CAS  Google Scholar 

  21. Larner J., Huang L.C., Schwartz C.F., Oswald A.S., Shen T.Y., Kinter M., Tang G.Z., Zeller K. Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphate contains galactosamine and D-chiroinositol. J. Biochem. Biophys. Res. Commun. 151: 1416, 1988.

    Article  CAS  Google Scholar 

  22. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248, 1976.

    Article  PubMed  CAS  Google Scholar 

  23. Fleig W.E., Noether-Fleig G., Fussgaenger R., Ditschuneit H. Modulation by a sulfonylurea of insulin-dependent glycogenosis, but not of insulin binding, in cultured rat hepatocytes. Diabetes 33: 285, 1984.

    Article  PubMed  CAS  Google Scholar 

  24. Hue L., Bontemps F., Hers H.G. The effect of glucose and of potassium ions on the interconversion of the two forms of glycogen Phosphorylase and of glycogen synthetase in isolated rat liver preparation. Biochem. J. 152: 105, 1975.

    PubMed Central  PubMed  CAS  Google Scholar 

  25. Albor A., Camara J., Mato J.M., Malaisse W.J., Valverde I. Metabolic labelling and partial characterization of glycolipids in pancreatic islet cells. Cell. Biochem. Funct. 9: 71, 1991.

    Article  PubMed  CAS  Google Scholar 

  26. Kreymann B., Ghatei M.A., Williams G., Bloom S.R. Glucagon-like peptide-1 7–36: a physiological incretin in man. Lancet 2: 1300, 1987.

    Article  PubMed  CAS  Google Scholar 

  27. Orskov C, Jeppesen J., Madsbad S., Holst J.J. Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J.Clin. Invest. 87: 415, 1991.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  28. Fukase N., Igarashi M., Takahashi H., Manaka H., Yamatani K., Daimon M., Tominaga M., Sasaki H. Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients. Diabet. Med. 10: 44, 1993.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Fundación Jiménez Díaz, Dpto. Metabolismo, Nutrición y Hormonas, Avda. Reyes Catolicos, 2, 28040, Madrid, Spain

    M. A. Trapote, F. Clemente, C. Galera, M. Morales, A. I. Alcántara, M. I. López-Delgado, M. L. Villanueva-Penacarrillo &  Isabel Valverde

Authors
  1. M. A. Trapote
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Clemente
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Galera
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Morales
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. I. Alcántara
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M. I. López-Delgado
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. L. Villanueva-Penacarrillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Isabel Valverde
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trapote, M.A., Clemente, F., Galera, C. et al. Inositolphosphoglycans are possible mediators of the glucagon-like peptide 1 (7–36)amide action in the liver. J Endocrinol Invest 19, 114–118 (1996). https://doi.org/10.1007/BF03349846

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349846

Key-words

Search

Navigation